{
  "meta": {
    "title": "Pathology_Mini_Test_2",
    "url": "https://brainandscalpel.vercel.app/pathology-mini-test-2-e6f7d950.html",
    "scrapedAt": "2025-11-30T07:33:03.621Z"
  },
  "questions": [
    {
      "id": 1,
      "choices": [
        {
          "id": 1,
          "text": "<p><span style=\"font-size:12.0pt;\">Coagulation defect</span></p>"
        },
        {
          "id": 2,
          "text": "<p><span style=\"font-size:12.0pt;\">Platelet function</span></p>"
        },
        {
          "id": 3,
          "text": "<p><span style=\"font-size:12.0pt;\">Fibrinolytic pathway</span></p>"
        },
        {
          "id": 4,
          "text": "<p><span style=\"font-size:12.0pt;\">All of the above</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Bleeding time (BT) is used clinically to screen for a significance in?</span></p>",
      "unique_key": "Q230740",
      "question_audio": null,
      "question_video": null,
      "map_id": 230740,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1000003
      ],
      "solution": "<p>Bleeding time is used to assess:</p><ol><li><strong>Platelet function</strong>: It evaluates the ability of platelets to aggregate and form a plug to stop bleeding.</li><li><strong>Vascular integrity</strong>: It assesses the ability of blood vessels to constrict and stop bleeding.</li><li><strong>Coagulation cascade</strong>: It indirectly evaluates the functioning of the coagulation cascade, including the <strong>fibrinolytic</strong> pathway.</li><li><strong>Bleeding disorders</strong>: It helps diagnose bleeding disorders such as:<ul><li>Platelet dysfunction (e.g., thrombocytopenia, thrombasthenia)</li><li>Von Willebrand disease</li><li>Hemophilia</li><li>Coagulation factor deficiencies</li></ul></li><li><strong>Monitoring</strong>:<ul><li>Effects of antiplatelet or anticoagulant medications</li><li>Progression of bleeding disorders</li><li>Response to treatment</li></ul></li></ol><p><strong>Reference: </strong>HARSHMOHAN textbook of pathology, 7<sup>TH</sup> EDITION, PAGE NUMBER: 307.</p>",
      "correct_choice_id": 4,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 2,
      "choices": [
        {
          "id": 11,
          "text": "<p><span style=\"font-size:12.0pt;\">Inflammation related to portal tracts</span></p>"
        },
        {
          "id": 12,
          "text": "<p><span style=\"font-size:12.0pt;\">Absence of necrosis</span></p>"
        },
        {
          "id": 13,
          "text": "<p><span style=\"font-size:12.0pt;\">Ductular reaction</span></p>"
        },
        {
          "id": 14,
          "text": "<p><span style=\"font-size:12.0pt;\">No fibrosis</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following pathological feature distinguishes chronic hepatitis from acute hepatitis?</span></p>",
      "unique_key": "Q230741",
      "question_audio": null,
      "question_video": null,
      "map_id": 230741,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1000003
      ],
      "solution": "<p><strong>Chronic hepatitis</strong> is characterized by:</p><ul><li><strong>Fibrosis</strong> (scarring) in the liver, ductular reaction is often present in areas of fibrosis.</li><li>Inflammation extending <strong>beyond portal tracts</strong> into the lobules.</li><li>Piecemeal<strong> necrosis</strong> (interface hepatitis)</li><li>Regenerative changes (e.g., nodular regeneration)</li></ul><p><strong>Acute hepatitis</strong>, on the other hand, typically shows:</p><ul><li>No fibrosis</li><li>Inflammation limited to portal tracts</li><li>Lobular disarray and hepatocyte necrosis</li><li>No regenerative changes</li><li>Bridging necrosis can occur in severe acute hepatitis.</li></ul><img class=\"w-100\" style=\"height:auto;display:block;vertical-align: middle;border:0; \"src=\"https://d10ehao5y6v0v4.cloudfront.net/V2LBNEETPG/QuizOct2024/PathologyMiniII15102024/2E.jpg\"><p><strong>Reference: </strong>ROBBINS &amp; COTRAN pathologic basics of disease, 10<sup>TH</sup> EDITION, PAGE NUMBER. 838.</p>",
      "correct_choice_id": 13,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 3,
      "choices": [
        {
          "id": 21,
          "text": "<p><span style=\"font-size:12.0pt;\">17p</span></p>"
        },
        {
          "id": 22,
          "text": "<p><span style=\"font-size:12.0pt;\">17q</span></p>"
        },
        {
          "id": 23,
          "text": "<p><span style=\"font-size:12.0pt;\">13q</span></p>"
        },
        {
          "id": 24,
          "text": "<p><span style=\"font-size:12.0pt;\">13p</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">BRCA1 gene located on which chromosome?</span></p>",
      "unique_key": "Q230742",
      "question_audio": null,
      "question_video": null,
      "map_id": 230742,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1000003
      ],
      "solution": "<ul><li>BRCA1 located on chromosome</li><li>BRCA2 located on chromosome <strong>3</strong>.</li></ul><img class=\"w-100\" style=\"height:auto;display:block;vertical-align: middle;border:0; \"src=\"https://d10ehao5y6v0v4.cloudfront.net/V2LBNEETPG/QuizOct2024/PathologyMiniII15102024/3E.jpg\"><p>Both BRCA1 and BRCA2 are <strong>tumor suppressor genes</strong>, meaning their normal function helps to prevent uncontrolled cell growth.</p><p>These genes produce proteins involved in the repair of DNA damage via <strong>homologous recombination repair</strong>, a critical process for maintaining genomic integrity.</p><p><strong>Reference: </strong>ROBBINS AND COTRAN pathologic basics of disease, 10<sup>TH</sup> EDITION, PAGE NUMBER. 1047.</p>",
      "correct_choice_id": 22,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 4,
      "choices": [
        {
          "id": 31,
          "text": "<p><span style=\"font-size:12.0pt;\">Relative degree of keratinization</span></p>"
        },
        {
          "id": 32,
          "text": "<p><span style=\"font-size:12.0pt;\">Growth rate of tumor</span></p>"
        },
        {
          "id": 33,
          "text": "<p><span style=\"font-size:12.0pt;\">Mitotic rate</span></p>"
        },
        {
          "id": 34,
          "text": "<p><span style=\"font-size:12.0pt;\">All of the above</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">In case of oral squamous cell carcinoma, the degree of histologic differentiation is determined by?</span></p>",
      "unique_key": "Q230743",
      "question_audio": null,
      "question_video": null,
      "map_id": 230743,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1000003
      ],
      "solution": "<p>The degree of keratinization is related to the histologic differentiation of a tumor, particularly in squamous cell carcinomas (SCCs), as follows:</p><ul><li>Well-differentiated SCCs: <strong>High degree</strong> of keratinization, with prominent keratin pearls and intercellular bridges.</li><li>Moderately differentiated SCCs: <strong>Moderate degree</strong> of keratinization, with some keratin pearls and intercellular bridges.</li><li>Poorly differentiated SCCs: <strong>Low degree</strong> of keratinization, with few or no keratin pearls and intercellular bridges.</li></ul><p><strong>KERATINISATION:</strong></p><ul><li>Keratinization is a key feature of squamous cell differentiation, and its degree serves as an indicator of the tumor's resemblance to normal squamous epithelium.</li></ul><img class=\"w-100\" style=\"height:auto;display:block;vertical-align: middle;border:0; \"src=\"https://d10ehao5y6v0v4.cloudfront.net/V2LBNEETPG/QuizOct2024/PathologyMiniII15102024/4E.jpg\"><ul><li>Tumors with <strong>high keratinization are more differentiated, meaning they retain more of the characteristics of normal cells, whereas those with low keratinization are less differentiated, meaning they have lost more of their normal cellular features.</strong></li></ul><p><strong>Option B:</strong> The growth rate of a tumor is <strong>not directly related</strong> to its degree of histologic differentiation for several reasons:</p><ul><li><strong>Tumor heterogeneity</strong>: Tumors are composed of diverse cell populations, each with varying growth rates and differentiation levels.</li><li><strong>Genetic mutations</strong>: Specific genetic mutations can drive rapid growth regardless of differentiation status.</li><li><strong>Microenvironmental factors</strong>: The tumor microenvironment, including blood supply, immune response, and stromal interactions, influences growth rates.</li><li><strong>Angiogenesis</strong>: Tumors can develop new blood vessels to support growth, regardless of differentiation.</li><li><strong>Cancer stem cells</strong>: A small subpopulation of cancer stem cells can drive tumor growth and recurrence, independent of differentiation.</li><li><strong>Epigenetic changes</strong>: Epigenetic modifications can affect gene expression, leading to increased growth rates without altering differentiation.</li></ul><p><strong>Option C</strong>: Mitotic rate, which refers to <strong>the frequency of cell divisions</strong>, is not directly related to the degree of histologic differentiation of a tumor for several reasons:</p><ul><li>Mitotic rate is a <strong>measure of proliferation</strong>, not differentiation: Mitosis measures how quickly cells divide, whereas differentiation refers to the degree of cellular specialization.</li><li>Differentiated cells can still proliferate rapidly: <strong>Well-differentiated</strong> tumor cells can exhibit <strong>high mitotic rates, </strong>especially in certain tumor types like lymphomas.</li><li>Undifferentiated cells can proliferate slowly: <strong>Poorly differentiated or anaplastic </strong>tumor cells may exhibit <strong>low mitotic rates</strong> due to various factors like cellular stress or microenvironmental limitations.</li></ul><p><strong>Reference: ROBBINS &amp; COTRAN pathologic basics of disease, 10<sup>TH</sup> EDITION, PAGE NUMBER:737.</strong></p>",
      "correct_choice_id": 31,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5,
      "choices": [
        {
          "id": 41,
          "text": "<p><span style=\"font-size:12.0pt;\">Wright's stain</span></p>"
        },
        {
          "id": 42,
          "text": "<p><span style=\"font-size:12.0pt;\">Giemsa stain</span></p>"
        },
        {
          "id": 43,
          "text": "<p><span style=\"font-size:12.0pt;\">Supravital stain</span></p>"
        },
        {
          "id": 44,
          "text": "<p><span style=\"font-size:12.0pt;\">Hematoxylin and Eosin (H&E) stain</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following stains is commonly used to visualize reticulocytes in peripheral blood?</span></p>",
      "unique_key": "Q230744",
      "question_audio": null,
      "question_video": null,
      "map_id": 230744,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1000003
      ],
      "solution": "<p>C. Supravital stain selectively stains the <strong>RNA</strong> in reticulocytes, allowing them to be visualized under a microscope.</p><img class=\"w-100\" style=\"height:auto;display:block;vertical-align: middle;border:0; \"src=\"https://d10ehao5y6v0v4.cloudfront.net/V2LBNEETPG/QuizOct2024/PathologyMiniII15102024/5E.jpg\"><ul><li>This is in contrast to other stains like Wright's, Giemsa, and H&amp;E, which are used for general blood cell morphology but do not specifically highlight reticulocytes.</li><li><strong>Brilliant Cresyl Blue</strong> (BCB) stain and <strong>new</strong> <strong>methylene blue</strong> stain (NMB) are examples of supravital stains.</li></ul><p><strong>Option A &amp; B.</strong> Wright's stain and Giemsa stain are used for general blood cell morphology.</p><p><strong>Option D</strong>: H&amp;E stain is used for histopathology, not for blood cell staining.</p><p><strong>Reference: </strong>ROBBINS &amp; COTRAN pathologic basics of disease, 10<sup>TH</sup> EDITION, PAGE NUMBER. 637.</p>",
      "correct_choice_id": 43,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6,
      "choices": [
        {
          "id": 51,
          "text": "<p><span style=\"font-size:12.0pt;\">ATP7B</span></p>"
        },
        {
          "id": 52,
          "text": "<p><span style=\"font-size:12.0pt;\">HAMP</span></p>"
        },
        {
          "id": 53,
          "text": "<p><span style=\"font-size:12.0pt;\">CTFR</span></p>"
        },
        {
          "id": 54,
          "text": "<p><span style=\"font-size:12.0pt;\">APC</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 25 year old patient presents with tremor, dysarthria, and difficulty walking. Physical examination reveals Kayser-Fleischer rings in the cornea. Laboratory tests show: Low serum ceruloplasmin levels, Elevated urinary copper excretion and Normal liver function tests. Which of the following gene mutation have caused this?</span></p>",
      "unique_key": "Q230745",
      "question_audio": null,
      "question_video": null,
      "map_id": 230745,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1000003
      ],
      "solution": "<ul><li>The features of the this patient suggest he/she is having <strong>Wilson disease </strong>which is a severe condition that can lead to liver failure, neurological symptoms, and psychiatric problems if left untreated.</li><li>Mutations in ATP7B cause Wilson Disease, a rare genetic disorder characterized by excessive copper accumulation in the liver, brain, and other organs.</li><li>The ATP7B gene provides instructions for making a protein called <strong>copper-transporting ATPase 2</strong>. This protein plays a crucial role in the transport of copper from the liver to other parts of the body.</li><li>Here are some key points about the ATP7B gene:</li><li>Location: Chromosome</li><li>Function: <strong>Copper transport and metabolism</strong></li></ul><p>Option B: HAMP gene (also known as HEPC or HFE2) provides instructions for making a protein called <strong>hepcidin</strong>.</p><ul><li>Hepcidin plays a crucial role in regulating iron levels in the body by controlling the absorption and distribution of iron.</li><li><strong>Mutations in the HAMP gene can lead to:</strong><ul><li><strong>Hereditary hemochromatosis (HH) type 2B</strong></li><li><strong>Juvenile hemochromatosis</strong></li><li><strong>Iron overload disorders</strong></li></ul></li></ul><p><strong>Option C</strong>: The CTFR gene (<strong>cystic fibrosis transmembrane conductance regulator</strong>) provides instructions for making a protein called CFTR (cystic fibrosis transmembrane conductance regulator).</p><ul><li>This protein plays a crucial role in regulating the transport of salt and water in and out of cells.</li><li>Mutations in the CTFR gene cause cystic fibrosis.</li></ul><p><strong>Option D:</strong> The APC gene is a <strong>tumor suppressor gene</strong>, meaning it helps prevent cancer by regulating cell growth and division.</p><ul><li>Inheritance of APC gene mutations follows an <strong>autosomal dominant </strong>pattern</li><li>Mutations in the APC gene can lead to:<ol><li><strong>Familial Adenomatous Polyposis (FAP):</strong> A rare genetic disorder characterized by the development of hundreds to thousands of colorectal polyps, increasing the risk of colorectal cancer.</li><li><strong>Gardner syndrome:</strong> A variant of FAP with additional symptoms like osteomas, epidermoid cysts, and dental abnormalities.</li><li><strong>Turcot syndrome:</strong> A rare condition with symptoms of FAP and brain tumors.</li><li><strong>Colorectal cancer</strong>: APC mutations can also increase the risk of sporadic colorectal cancer.</li></ol></li></ul><p><strong>Reference: </strong>ROBBINS &amp; COTRAN pathologic basics of disease, 10<sup>TH</sup> EDITION, PAGE NUMBER. 851.</p>",
      "correct_choice_id": 51,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 7,
      "choices": [
        {
          "id": 61,
          "text": "<p><span style=\"font-size:12.0pt;\">AML M4</span></p>"
        },
        {
          "id": 62,
          "text": "<p><span style=\"font-size:12.0pt;\">AML M7</span></p>"
        },
        {
          "id": 63,
          "text": "<p><span style=\"font-size:12.0pt;\">AML M5</span></p>"
        },
        {
          "id": 64,
          "text": "<p><span style=\"font-size:12.0pt;\">AML M3</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Most common type of AML associated with Down syndrome?</span></p>",
      "unique_key": "Q230746",
      "question_audio": null,
      "question_video": null,
      "map_id": 230746,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1000003
      ],
      "solution": "<img class=\"w-100\" style=\"height:auto;display:block;vertical-align: middle;border:0; \"src=\"https://d10ehao5y6v0v4.cloudfront.net/V2LBNEETPG/QuizOct2024/PathologyMiniII15102024/7E.jpg\"><p>AML M7(Acute megakaryoblastic leukemia) is the most common type in Down syndrome.</p><p><strong>Reference: </strong>ROBBINS &amp; COTRAN pathologic basics of disease, 10<sup>TH</sup> EDITION, PAGE NUMBER. 618.</p>",
      "correct_choice_id": 62,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 8,
      "choices": [
        {
          "id": 71,
          "text": "<p><span style=\"font-size:12.0pt;\">ER</span></p>"
        },
        {
          "id": 72,
          "text": "<p><span style=\"font-size:12.0pt;\">PR</span></p>"
        },
        {
          "id": 73,
          "text": "<p><span style=\"font-size:12.0pt;\">Ki67</span></p>"
        },
        {
          "id": 74,
          "text": "<p><span style=\"font-size:12.0pt;\">HER2</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Shown picture is of IHC stain(positive) in case of breast tumor. Which antibody is used for the dignosis?<br><img class=\"w-100\" style=\"height:auto;display:block;vertical-align: middle;border:0; \"src=\"https://d10ehao5y6v0v4.cloudfront.net/V2LBNEETPG/QuizOct2024/PathologyMiniII15102024/8Q.jpg\"></span></p>",
      "unique_key": "Q230747",
      "question_audio": null,
      "question_video": null,
      "map_id": 230747,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1000003
      ],
      "solution": "<p>Picture shown suggests <strong>Strong, complete membranous</strong> positive staining, HER2 antibody shows membranous staining.</p><p>Interpretation:</p><img class=\"w-100\" style=\"height:auto;display:block;vertical-align: middle;border:0; \"src=\"https://d10ehao5y6v0v4.cloudfront.net/V2LBNEETPG/QuizOct2024/PathologyMiniII15102024/8E.jpg\"><p><strong>Options A,B &amp; C:</strong> ER, PR AND Ki67 antibodies show <strong>nuclear staining</strong>.</p><img class=\"w-100\" style=\"height:auto;display:block;vertical-align: middle;border:0; \"src=\"https://d10ehao5y6v0v4.cloudfront.net/V2LBNEETPG/QuizOct2024/PathologyMiniII15102024/8E1.jpg\"><p><strong>Reference: </strong>ROBBINS &amp; COTRAN pathologic basics of disease, 10<sup>TH</sup> EDITION, PAGE NUMBER. 1048.</p>",
      "correct_choice_id": 74,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 9,
      "choices": [
        {
          "id": 81,
          "text": "<p><span style=\"font-size:12.0pt;\">Fatty streaks</span></p>"
        },
        {
          "id": 82,
          "text": "<p><span style=\"font-size:12.0pt;\">Atherosclerotic plaque</span></p>"
        },
        {
          "id": 83,
          "text": "<p><span style=\"font-size:12.0pt;\">Aneurysm</span></p>"
        },
        {
          "id": 84,
          "text": "<p><span style=\"font-size:12.0pt;\">Ulcertion</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">What is the earliest lesion in atherosclerosis?</span></p>",
      "unique_key": "Q230748",
      "question_audio": null,
      "question_video": null,
      "map_id": 230748,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1000003
      ],
      "solution": "<p>A fatty streak is an early sign of atherosclerosis.</p><ul><li>A fatty streak is a <strong>flat, yellowish patch</strong> on the innermost layer of the artery wall, composed of:</li><li>Lipid-laden macrophages (foam cells)</li><li>T lymphocytes</li><li>Smooth muscle cells</li></ul><img class=\"w-100\" style=\"height:auto;display:block;vertical-align: middle;border:0; \"src=\"https://d10ehao5y6v0v4.cloudfront.net/V2LBNEETPG/QuizOct2024/PathologyMiniII15102024/9E.jpg\"><p><strong>Option B:</strong> An atherosclerotic plaque is a complex lesion that forms in the artery wall, leading to atherosclerosis.</p><ul><li>Composition: Atherosclerotic plaques consist of<ul><li>Lipid core (cholesterol, triglycerides)</li><li>Fibrous cap (smooth muscle cells, collagen)</li><li>Inflammatory cells (macrophages, T lymphocytes)</li><li>Calcification</li></ul></li></ul><img class=\"w-100\" style=\"height:auto;display:block;vertical-align: middle;border:0; \"src=\"https://d10ehao5y6v0v4.cloudfront.net/V2LBNEETPG/QuizOct2024/PathologyMiniII15102024/9E1.jpg\"><p><strong>Option C:</strong> Aneurysm formation: Atherosclerosis induced pressure or ischemic atrophy of underlying media, with loss of elastic tissue, causes weakness and potential rupture.</p><p><strong>Option D:</strong> Ulceration of the surface of atheromatous plaques exposes the blood stream to highly thrombogenic substances and leads to <strong>thrombosis</strong>.</p><p><strong>Reference: </strong>ROBBINS &amp; COTRAN pathologic basics of disease, 10<sup>TH</sup> EDITION, PAGE NUMBER. 499.</p>",
      "correct_choice_id": 81,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 10,
      "choices": [
        {
          "id": 91,
          "text": "<p><span style=\"font-size:12.0pt;\">No association with ANCA</span></p>"
        },
        {
          "id": 92,
          "text": "<p><span style=\"font-size:12.0pt;\">Most commonly pulmonary involvement</span></p>"
        },
        {
          "id": 93,
          "text": "<p><span style=\"font-size:12.0pt;\">Immunosuppression can yield remissions in 90% of cases</span></p>"
        },
        {
          "id": 94,
          "text": "<p><span style=\"font-size:12.0pt;\">All stages of activity coexist in different vessels or even within the same vessel.</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 30-year-old woman presents with severe abdominal pain, vomiting and blood stools. CT scan shows ruptured hepatic artery and aneurysm. Histopathological findings show fibrinoid necrosis, transmural necrotizing inflammation and luminal thrombosis of arterial wall. All of the following is true about this condition except:</span></p>",
      "unique_key": "Q230749",
      "question_audio": null,
      "question_video": null,
      "map_id": 230749,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1000003
      ],
      "solution": "<p>The clinical features of this patient suggest that she is having <strong>Polyarteritis Nodosa (PAN) </strong>which is a systemic vasculitis of small or medium sized muscular arteries.</p><p>It <strong>spares </strong>pulmonary circulation, so option B is wrong for this condition and that's why it is <strong>correct.</strong></p><p>Other options(A,B &amp; C) are true for this disease.</p><p><strong>Reference</strong>: ROBBINS &amp; COTRAN pathologic basics of disease, 10<sup>TH</sup> EDITION, PAGE NUMBER. 513.</p>",
      "correct_choice_id": 92,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11,
      "choices": [
        {
          "id": 101,
          "text": "<p><span style=\"font-size:12.0pt;\">Activation of matrix metalloproteinases (MMPs)</span></p>"
        },
        {
          "id": 102,
          "text": "<p><span style=\"font-size:12.0pt;\">Increased expression of vascular endothelial growth factor (VEGF)</span></p>"
        },
        {
          "id": 103,
          "text": "<p><span style=\"font-size:12.0pt;\">Mutations in the COL3A1 gene</span></p>"
        },
        {
          "id": 104,
          "text": "<p><span style=\"font-size:12.0pt;\">Enhanced activity of inflammatory cytokines (e.g., TNF-&alpha;)</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 50-year-old male with hypertension and smoking history presents with:<br> - Ascending aortic aneurysm (5 cm diameter) <br> - Bicuspid aortic valve<br> - Family history of aneurysm<br> What is the most likely underlying molecular mechanism contributing to aneurysm formation?</span></p>",
      "unique_key": "Q230750",
      "question_audio": null,
      "question_video": null,
      "map_id": 230750,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1000003
      ],
      "solution": "<ul><li>MMPs <strong>breaks down</strong> extracellular matrix proteins (e.g., collagen, elastin)</li><li><strong>Increased</strong> MMP activity <strong>contributes</strong> to aneurysm formation and progression.</li><li>Hypertension and smoking exacerbate MMP activation.</li></ul><p><strong>Option B</strong>. VEGF is involved in <strong>angiogenesis</strong>, not directly related to aneurysm formation.</p><p><strong>Option C.</strong> COL3A1 mutations are associated with <strong>Ehlers-Danlos syndrome</strong>, but not the primary mechanism here.</p><p><strong>Option D</strong>. Inflammatory cytokines contribute to aneurysm formation, but MMP activation is more directly involved.</p><p><strong>Reference: </strong>ROBBINS &amp; COTRAN pathologic basics of disease, 10<sup>TH</sup> EDITION, PAGE NUMBER. 504.</p>",
      "correct_choice_id": 101,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 12,
      "choices": [
        {
          "id": 111,
          "text": "<p><span style=\"font-size:12.0pt;\">Acute Lymphoblastic Leukemia (ALL)</span></p>"
        },
        {
          "id": 112,
          "text": "<p><span style=\"font-size:12.0pt;\">Acute Myeloid Leukemia (AML)</span></p>"
        },
        {
          "id": 113,
          "text": "<p><span style=\"font-size:12.0pt;\">Juvenile Myelomonocytic Leukemia (JMML)</span></p>"
        },
        {
          "id": 114,
          "text": "<p><span style=\"font-size:12.0pt;\">Myelodysplastic Syndrome (MDS)</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 4-year-old child presents with Anemia (Hb 6 g/dL), Thrombocytopenia (15,000/&mu;L), Leukocytosis (80,000/&mu;L), Bone marrow blasts (90%). Immunophenotyping reveals: CD10+, CD19+, TdT+. What is the most likely diagnosis?</span></p>",
      "unique_key": "Q230751",
      "question_audio": null,
      "question_video": null,
      "map_id": 230751,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1000003
      ],
      "solution": "<p>The patient's clinical presentation and laboratory results suggest:</p><ol><li>Anemia and thrombocytopenia indicate bone marrow failure.</li><li>Leukocytosis with 90% bone marrow blasts suggests a hematological malignancy.</li></ol><img class=\"w-100\" style=\"height:auto;display:block;vertical-align: middle;border:0; \"src=\"https://d10ehao5y6v0v4.cloudfront.net/V2LBNEETPG/QuizOct2024/PathologyMiniII15102024/12E.jpg\"><ol start=\"3\"><li>Immunophenotyping reveals:</li></ol><p><strong>CD10+: Common acute lymphoblastic leukemia antigen (CALLA).</strong></p><p><strong>CD19+: B-cell marker</strong>.</p><p><strong>TdT+: Terminal deoxynucleotidyl transferase, indicative of lymphoblasts.</strong></p><p>These findings are characteristic of <strong>B-cell Acute Lymphoblastic Leukemia (B-ALL), a subtype of ALL.</strong></p><p><strong>Option B.</strong> Acute Myeloid Leukemia (AML): Typically presents with myeloid markers <strong>(e.g., CD33, CD117) </strong>and different cytogenetic abnormalities.</p><p><strong>Option C</strong>. Juvenile Myelomonocytic Leukemia (JMML): Characterized by <strong>monocytosis, splenomegaly</strong>, and specific genetic mutations.</p><p><strong>Option D</strong>. Myelodysplastic Syndrome (MDS): Typically presents with <strong>cytopenias, bone marrow dysplasia</strong>, and specific genetic abnormalities.</p><p><strong>Reference: </strong>ROBBINS &amp; COTRAN pathologic basics of disease, 10<sup>TH</sup> EDITION, PAGE NUMBER. 596.</p>",
      "correct_choice_id": 111,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 13,
      "choices": [
        {
          "id": 121,
          "text": "<p><span style=\"font-size:12.0pt;\">Excess alpha-globin chains</span></p>"
        },
        {
          "id": 122,
          "text": "<p><span style=\"font-size:12.0pt;\">Reduced alpha-globin chain synthesis</span></p>"
        },
        {
          "id": 123,
          "text": "<p><span style=\"font-size:12.0pt;\">Increased beta-globin chain synthesis</span></p>"
        },
        {
          "id": 124,
          "text": "<p><span style=\"font-size:12.0pt;\">Hemoglobin H formation</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following is a characteristic feature of Alpha-Thalassemia?</span></p>",
      "unique_key": "Q230752",
      "question_audio": null,
      "question_video": null,
      "map_id": 230752,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1000003
      ],
      "solution": "<ul><li>Alpha-Thalassemia is a genetic disorder characterized by:<ol><li><strong>Reduced or absent</strong> production of alpha-globin chains.</li><li><strong>Impaired</strong> hemoglobin synthesis.</li><li>Variable clinical severity.</li></ol></li></ul><img class=\"w-100\" style=\"height:auto;display:block;vertical-align: middle;border:0; \"src=\"https://d10ehao5y6v0v4.cloudfront.net/V2LBNEETPG/QuizOct2024/PathologyMiniII15102024/13E.jpg\"><p>The correct answer, <strong>B)</strong> Reduced alpha-globin chain synthesis, reflects the primary molecular defect in Alpha-Thalassemia.</p><p><strong>Option A: </strong>Excess alpha-globin chains: This is actually a feature of <strong>Beta-Thalassemia,</strong> where excess alpha-globin chains accumulate</p><p><strong>Option C</strong>: Increased beta-globin chain synthesis: This is <strong>not a</strong> characteristic feature of Alpha-Thalassemia</p><p><strong>Option D</strong>: Hemoglobin H formation: While Hemoglobin H is formed in Alpha-Thalassemia, it's a consequence of the underlying defect, <strong>not the primary c</strong>haracteristic feature.</p><p><strong>Reference</strong>: ROBBINS AND COTRAN pathologic basics of disease 10<sup>TH</sup> EDITION, PAGE NUMBER. 647.</p>",
      "correct_choice_id": 122,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 14,
      "choices": [
        {
          "id": 131,
          "text": "<p><span style=\"font-size:12.0pt;\">Non-Alcoholic Fatty Liver Disease (NAFLD)</span></p>"
        },
        {
          "id": 132,
          "text": "<p><span style=\"font-size:12.0pt;\">Non-Alcoholic Steatohepatitis (NASH)</span></p>"
        },
        {
          "id": 133,
          "text": "<p><span style=\"font-size:12.0pt;\">Alcoholic Liver Disease</span></p>"
        },
        {
          "id": 134,
          "text": "<p><span style=\"font-size:12.0pt;\">Chronic Hepatitis C</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 45-year-old obese Non alcoholic female with type 2 diabetes presents with Elevated ALT (100 U/L), Elevated AST (80 U/L), Normal bilirubin. Liver biopsy shows:<br> - Steatosis (30%)<br> - Lobular inflammation<br> - Hepatocyte ballooning<br> What is the most likely diagnosis?</span></p>",
      "unique_key": "Q230753",
      "question_audio": null,
      "question_video": null,
      "map_id": 230753,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1000003
      ],
      "solution": "<p>Non-Alcoholic Steatohepatitis (NASH)</p><ul><li>Characterized by steatosis, lobular inflammation, and hepatocyte ballooning.</li><li>Indicates active liver injury.</li><li>History and clinical plus lab diagnosis favors the diagnosis of NASH.</li></ul><img class=\"w-100\" style=\"height:auto;display:block;vertical-align: middle;border:0; \"src=\"https://d10ehao5y6v0v4.cloudfront.net/V2LBNEETPG/QuizOct2024/PathologyMiniII15102024/14E.jpg\"><p>Option A. Non-Alcoholic Fatty Liver Disease (NAFLD)</p><ul><li>Characterized by steatosis (fat accumulation) <strong>without </strong></li><li>May progress to NASH.</li></ul><p>Option C. Alcoholic Liver Disease</p><ul><li>Related to excessive alcohol consumption.</li><li>Different clinical and histological features.</li></ul><p>Option D. Chronic Hepatitis C</p><ul><li>Caused by hepatitis C virus infection.</li><li>Distinct clinical and histological features.</li></ul><p><strong>Reference: </strong>ROBBINS &amp; COTRAN pathologic basics of disease, 10<sup>TH</sup> EDITION, PAGE NUMBER. 846.</p>",
      "correct_choice_id": 132,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 15,
      "choices": [
        {
          "id": 141,
          "text": "<p><span style=\"font-size:12.0pt;\">Luminal A</span></p>"
        },
        {
          "id": 142,
          "text": "<p><span style=\"font-size:12.0pt;\">Luminal B</span></p>"
        },
        {
          "id": 143,
          "text": "<p><span style=\"font-size:12.0pt;\">Basal-like</span></p>"
        },
        {
          "id": 144,
          "text": "<p><span style=\"font-size:12.0pt;\">HER2-enriched</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 45-year-old woman presents with:<br> - Invasive ductal carcinoma<br> - Tumor size 2.5 cm<br> - ER/PR/HER2-negative<br> - CK5/6-positive<br> What is the most likely subtype?</span></p>",
      "unique_key": "Q230754",
      "question_audio": null,
      "question_video": null,
      "map_id": 230754,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1000003
      ],
      "solution": "<p>The patient's clinical presentation and tumor characteristics point to a <strong>Triple-negative/Basal-like b</strong>reast cancer subtype:</p><ol><li>Invasive ductal carcinoma: <strong>Most common type</strong> of breast cancer.</li><li>Tumor size 2.5 cm: Indicates <strong>early-stage</strong> disease.</li><li>ER/PR/HER2-negative: <strong>Triple-negative</strong> status.</li><li>CK5/6-positive: <strong>Basal </strong>marker expression.</li></ol><img class=\"w-100\" style=\"height:auto;display:block;vertical-align: middle;border:0; \"src=\"https://d10ehao5y6v0v4.cloudfront.net/V2LBNEETPG/QuizOct2024/PathologyMiniII15102024/15E.jpg\"><p><strong>Option A.</strong> Luminal A:</p><ul><li>Typically ER-positive and/or PR-positive.</li><li>Low Ki-67 expression.</li></ul><p><strong>Option B</strong>. Luminal B:</p><ul><li>Typically ER-positive and/or PR-positive.</li><li>Higher Ki-67 expression.</li></ul><p><strong>Option D.</strong> HER2-enriched:</p><ul><li>HER2-positive status.</li></ul><p><strong>Reference: </strong>ROBBINS &amp; COTRAN pathologic basics of disease, 10<sup>TH</sup> EDITION, PAGE NUMBER. 1050.</p>",
      "correct_choice_id": 143,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    }
  ]
}